MAOB and Parkinson disease: Results: While the efficacy and safety of rasagiline as monotherapy in the early phase of PD are well established, there are very few systematic, randomized, controlled studies investigating the combination of MAO-B-inhibitors and levodopa in patients without motor fluctuations.